|
|
Canada:
During the week ending January 15, 2000, 10 influenza surveillance regions
reported widespread influenza activity: all five regions of Ontario, all three
regions of Saskatchewan, one region in Manitoba, and one region in New Brunswick
(maps). During the same week, sentinel physicians reported
96 cases of influenza-like illness (ILI) per 1000 patient visits. Since September
1999, the Laboratory Centre for Disease Control (LCDC) has received 29,450
reports of laboratory tests for influenza viruses: 4,427 (15%) were confirmed
as influenza A and 16 (0.05%) as influenza B (table). Since
September 1999, the Bureau of Microbiology, LCDC, has characterized 164 influenza
isolates; 160 were A/Sydney/5/97-like, 2 were A/Beijing/262/95-like (H1N1)
and 2 were B/Beijing/184/93-like.The provincial distribution of the A/Sydney-like
isolates is: BC (14); AB (26); SK (8); MB (2); ON (77); QC (13); NB (4); NS
(8); PE (1); NL (7). The A/Beijing-like isolates were from Ontario and the
B/Beijing-like isolates were from Alberta. The 1999-2000 influenza vaccine
includes the A/Beijing/262/95 (H1N1) strain. Concurrent with the increases
in influenza, LCDC has received reports from many provinces of laboratory
confirmed increases in respiratory syncytial virus (RSV).
United States:
During the week ending January 8, 2000 (week 1), 31 states reported widespread
influenza activity; 11 states reported regional activity. Sentinel physician
reports of ILI were at levels of 5%. The proportion of deaths due to pneumonia
and influenza was 9.3%; over 2% above the epidemic threshold. Since October
3, 1999, the US World Health Organization and National Respiratory and Enteric
Virus Surveillance System Collaborating Laboratories have tested a total of
34,536 respiratory specimens of which 5,876 (17%) yielded influenza virus
isolates; 5,862 (99.8%) were influenza type A and 14 (0.2%) were type B. Of
the subtyped A isolates 1,370 were A(H3N2) and 3 were A(H1N1). <http://www.cdc.gov/ncidod/diseases/flu/weekly.htm>
Outside of North America:
Great Britain reported increases in influenza activity, now within the range
of ‘higher than expected seasonal level’; mainly due to A(H3N2), but B has
also been detected. The Netherlands, Austria, Switzerland, France, Norway,
Denmark, Italy and the Czech Republic reported A(H3N2) virus isolates; the
isolates from France were further characterized as A/Sydney/5/97. Hungary
reported A(H3N2) and B. France reported that the rate of ILI reporting has
declined nationally. <http://www.grog.org/EuroGROG1.htm>
Russia reported influenza A(H3N2), A(H1N1), and B virus isolations. Since
October, 1999, four countries in Asia (China, Japan, Malaysia, and Thailand)
reported influenza virus isolations. China, Japan, and Malaysia have all identified
A(H3N2), and China has also identified B type. <http://www.who.int/csr/disease/influenza/en/index.html>
|
Reported number of influenza virus
(FV) tests performed and influenza virus identifications by participating
laboratories, Canada, 1999-2000
Reporting
laboratories by province |
January
9, 2000 - January 15, 2000 |
Total
FV tests |
Influenza
types and subtypes |
A (H1N1)
|
A (H3N2) |
A (not
subtyped) |
Type B |
NL |
116 |
0 |
0 |
20 |
0 |
PEI |
1 |
0 |
0 |
1 |
0 |
NB |
43 |
0 |
0 |
15 |
0 |
NS |
103 |
0 |
0 |
31 |
0 |
QC |
855 |
0 |
0 |
191 |
0 |
ON |
1789 |
0 |
0 |
452 |
0 |
MB |
137 |
0 |
0 |
32 |
0 |
SK |
282 |
0 |
0 |
65 |
0 |
AB |
474 |
0 |
0 |
35 |
0 |
BC |
185 |
0 |
0 |
28 |
0 |
Canada |
3985 |
0 |
0 |
870 |
0 |
|
Specimens from NT, YT, and NU are sent to reference laboratories in other
provinces.
Reporting
laboratories by province |
September
4, 1999 - January 15, 2000 |
Total
FV tests |
Influenza
types and subtypes |
A (H1N1)
|
A (H3N2)
|
A
(not subtyped) |
Type B
|
NL |
141 |
0 |
0 |
27 |
0 |
PEI |
38 |
0 |
0 |
6 |
0 |
NB |
109 |
0 |
0 |
29 |
0 |
NS |
595 |
0 |
0 |
96 |
0 |
QC |
4196 |
0 |
0 |
847 |
0 |
ON |
11037 |
0 |
4 |
1738 |
2 |
MB |
1624 |
0 |
0 |
171 |
0 |
SK |
2519 |
0 |
31 |
227 |
2 |
AB |
7752 |
0 |
0 |
1050 |
12 |
BC |
1439 |
0 |
0 |
236 |
0 |
Canada |
29450 |
0 |
35 |
4427 |
16 |
|
Specimens from NT, YT, and NU are sent to reference laboratories in other
provinces.
Abbreviations: Nova Scotia (NS), New Brunswick (NB),
Prince Edward Island (PE), Newfoundland/Labrador (NL), Quebec (QC), Ontario
(ON), Manitoba (MB), Saskatchewan (SK), Alberta (AB), British Columbia (BC),
Northwest Territories (NT), Yukon (YT), Nunavut (NU)
Respiratory virus laboratory detections in Canada, by geographic
region, are available weekly on the following website: < http://www.phac-aspc.gc.ca/bid-bmi/dsd-dsm/rvdi-divr/>
Influenza tests reported and percentage
of tests positive, Canada, by report week, 1999-2000
Influenza-like illness reporting rates, Canada,
by report week, 1999-2000
Number of influenza surveillance regions† reporting
widespread or localized influenza activity, Canada, by report week, 1999-2000
(N=53)
† sub-regions within the province or territory as defined by the provincial/territorial
epidemiologist
Please note that the above graphs may change as late returns come in.
Influenza Activity Level
by Influenza
Surveillance Regions, Canada
January 9 to 15, 2000 (Week 2)
![Map](/web/20061212070158im_/http://www.phac-aspc.gc.ca/fluwatch/99-00/w02_00/figures/0200mape.gif)
Click
on the map to view provinces/territories and maps for other weeks.
|
|
|
|
|
No Data |
No Activity |
Sporadic Activity |
Localized Activity |
Widespread Activity |
Definitions for the 1999-2000
season
|